Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Min-Jia Tan

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Chemistry & Biology|March 22, 2008
Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathwayMin-Jia Tan, Ji-Ming Ye, Nigel Turner, et al.
Acta Pharmacologica Sinica|June 7, 2026
Time-resolved proteomic and phosphoproteomic analysis reveals convergent and divergent biological perturbations induced by FDA-approved CDK4/6 inhibitors in hormone receptor-positive breast cancersShi-Yu Duan, Lin-Hui Zhai, Wei Zhang, et al.
Acta Pharmacologica Sinica|September 20, 2016
Biochemical features of the adhesion G protein-coupled receptor CD97 related to its auto-proteolysis and HeLa cell attachment activitiesLi-Yun Yang, Xiao-Fang Liu, Yang Yang, et al.
Acta Pharmacologica Sinica|July 15, 2022
Discovery of toxoflavin, a potent IRE1α inhibitor acting through structure-dependent oxidative inhibitionKai-Long Jiang, Chang-Mei Liu, Li-Tong Nie, et al.
The Journal of Biological Chemistry|December 17, 2014
Protein kinase A rescues microtubule affinity-regulating kinase 2-induced microtubule instability and neurite disruption by phosphorylating serine 409Si-Si Deng, Le-Yu Wu, Ya-Chao Wang, et al.
Acta Pharmacologica Sinica|August 4, 2023
Author Correction: Discovery of toxoflavin, a potent IRE1α inhibitor acting through structure-dependent oxidative inhibitionKai-Long Jiang, Chang-Mei Liu, Li-Tong Nie, et al.
Acta Pharmacologica Sinica|March 27, 2020
The novel cereblon modulator CC-885 inhibits mitophagy via selective degradation of BNIP3LBing-Bing Hao, Xiao-Jing Li, Xing-Long Jia, et al.
Acta Pharmacologica Sinica|November 20, 2024
Comprehensive multi-omics analysis elucidates colchicine-induced toxicity mechanisms and unveils the therapeutic potential of MLN4924 and kinase inhibitorsLin-Hui Zhai, Xing-Long Jia, Yu-Lu Chen, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Chemistry & Biology|March 22, 2008
Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathwayMin-Jia Tan, Ji-Ming Ye, Nigel Turner, et al.
Acta Pharmacologica Sinica|June 7, 2026
Time-resolved proteomic and phosphoproteomic analysis reveals convergent and divergent biological perturbations induced by FDA-approved CDK4/6 inhibitors in hormone receptor-positive breast cancersShi-Yu Duan, Lin-Hui Zhai, Wei Zhang, et al.
Acta Pharmacologica Sinica|September 20, 2016
Biochemical features of the adhesion G protein-coupled receptor CD97 related to its auto-proteolysis and HeLa cell attachment activitiesLi-Yun Yang, Xiao-Fang Liu, Yang Yang, et al.
Acta Pharmacologica Sinica|July 15, 2022
Discovery of toxoflavin, a potent IRE1α inhibitor acting through structure-dependent oxidative inhibitionKai-Long Jiang, Chang-Mei Liu, Li-Tong Nie, et al.
The Journal of Biological Chemistry|December 17, 2014
Protein kinase A rescues microtubule affinity-regulating kinase 2-induced microtubule instability and neurite disruption by phosphorylating serine 409Si-Si Deng, Le-Yu Wu, Ya-Chao Wang, et al.
Acta Pharmacologica Sinica|August 4, 2023
Author Correction: Discovery of toxoflavin, a potent IRE1α inhibitor acting through structure-dependent oxidative inhibitionKai-Long Jiang, Chang-Mei Liu, Li-Tong Nie, et al.
Acta Pharmacologica Sinica|March 27, 2020
The novel cereblon modulator CC-885 inhibits mitophagy via selective degradation of BNIP3LBing-Bing Hao, Xiao-Jing Li, Xing-Long Jia, et al.
Acta Pharmacologica Sinica|November 20, 2024
Comprehensive multi-omics analysis elucidates colchicine-induced toxicity mechanisms and unveils the therapeutic potential of MLN4924 and kinase inhibitorsLin-Hui Zhai, Xing-Long Jia, Yu-Lu Chen, et al.
Pageof 2